Bruker Q2 GAAP diluted loss widens to $(0.41) per share; revenue rises 5.2% to $838.5 million year-over-year - BRKR News | RalliesBruker Q2 GAAP diluted loss widens to $(0.41) per share; revenue rises 5.2% to $838.5 million year-over-year
B
BRKR• Full-year 2026 outlook reaffirmed
- FY2026 outlook reaffirmed on operations, with revenue guided at USD 3.54 billion to USD 3.57 billion; non-GAAP EPS seen at USD 2.10 to USD 2.15.
Non-GAAP profit and margins improve
- Non-GAAP diluted EPS climbed 53.13% to USD 0.49; non-GAAP operating margin widened 5.1 percentage points to 14.1%.
Bruker reports Q2 revenue growth and wider GAAP loss
- Bruker Q2 2026 revenue rose 5.2% year-over-year to USD 838.5 million; GAAP diluted EPS turned to a loss of USD 0.41.
- GAAP operating result swung to a loss of USD 65.3 million, reflecting USD 134.9 million of non-cash goodwill impairment charges.
Scientific Instruments bookings and segment revenue rise
- Scientific Instruments bookings increased 10% organically year-over-year with book-to-bill above 1.0x; segment revenue rose 4.7% to USD 767.3 million.
•
